Quanta Therapeutics is a private biopharmaceutical company focused on developing innovative oral therapeutics for RAS-driven cancers, particularly through the use of allosteric inhibitors targeting KRAS mutations
Quanta Therapeutics is a private biopharmaceutical company focused on developing innovative oral therapeutics for RAS-driven cancers, particularly through the use of allosteric inhibitors targeting KRAS mutations.